What question did this study set out to answer?

To compare the safety and efficacy of intravenous labetalol versus intravenous hydralazine for acutely reducing severe blood pressure in the puerperium.

January 1, 2007Hypertension in Pregnancy

Management of Severe Hypertension in the Postpartum Period with Intravenous Hydralazine or Labetalol: A Randomized Clinical Trial

View Full Paper

Ask AI

Bookmark

Authors

PGPaulino Vigil‐De GraciaComplejo Hospitalario Dr. Arnulfo Arias Madrid EREsteban RuizUniversidad Católica de Córdoba JLJuan Carlos Rivero LópezUniversidad de Ciencias Médicas de la Habana

Discussion

Member takes

Implication

Randomized trial reveals equivalent blood pressure lowering with intravenous hydralazine or labetalol in postpartum women, indicating both regimens are safe and effective.

Key Points

To compare the safety and efficacy of intravenous labetalol versus intravenous hydralazine for acutely reducing severe blood pressure in the puerperium.
Randomized clinical trial conducted in a critical care gynecology and obstetrics department in Panama involving 82 women with severe postpartum hypertension.
Participants were randomized to intravenous hydralazine (5 mg slow bolus every 20 minutes, maximum five doses) or intravenous labetalol (20 mg bolus, then 40 mg, followed by 80 mg every 20 minutes, maximum 300 mg) to achieve blood pressure control.
A total of 42 women were assigned to hydralazine and 40 to labetalol, with no significant differences in baseline characteristics between the two arms.
No significant differences occurred between treatments regarding maternal side effects or treatment failure; persistent severe hypertension occurred in 1 of 40 women (2.5%) receiving labetalol and 0 of 42 (0%) receiving hydralazine, with zero maternal deaths overall.

Cite This Study

Gracia et al. (2007) studied this question.

synapsesocial.com/papers/6a8150f7ada1eccddc33b114 https://doi.org/10.1080/10641950701204430

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial reveals equivalent blood pressure lowering with intravenous hydralazine or labetalol in postpartum women, indicating both regimens are safe and effective.

Management of Severe Hypertension in the Postpartum Period with Intravenous Hydralazine or Labetalol: A Randomized Clinical Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Management of Severe Hypertension in the Postpartum Period with Intravenous Hydralazine or Labetalol: A Randomized Clinical Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider